Beta-adrenoceptor antagonists affect amyloid nanostructure:  amyloid hydrogels as drug delivery vehicles

Jenifer Mains; Dimitrios A. Lamprou; Lisa McIntosh; Iain D. H. Oswald; Andrew J. Urquhart

doi:10.1039/c3cc41583j

Beta-adrenoceptor antagonists affect amyloid nanostructure: amyloid hydrogels as drug delivery vehicles

Jenifer Mains, Dimitrios A. Lamprou, Lisa McIntosh, Iain D. H. Oswald, Andrew J. Urquhart

University of Strathclyde

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

Original language	English
Journal	Chemical Communications
Volume	49
Issue number	44
Pages (from-to)	5082-5084
ISSN	1359-7345
DOIs	https://doi.org/10.1039/c3cc41583j
Publication status	Published - 2013
Externally published	Yes

Access to Document

10.1039/c3cc41583j

OpenUrl availability

Full text

Cite this

@article{8a920f702e4742b1a4c9e3c53919c26e,

title = "Beta-adrenoceptor antagonists affect amyloid nanostructure: amyloid hydrogels as drug delivery vehicles",

abstract = "Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.",

author = "Jenifer Mains and Lamprou, {Dimitrios A.} and Lisa McIntosh and Oswald, {Iain D. H.} and Urquhart, {Andrew J.}",

year = "2013",

doi = "10.1039/c3cc41583j",

language = "English",

volume = "49",

pages = "5082--5084",

journal = "Chemical Communications",

issn = "1359-7345",

number = "44",

}

TY - JOUR

T1 - Beta-adrenoceptor antagonists affect amyloid nanostructure

T2 - amyloid hydrogels as drug delivery vehicles

AU - Mains, Jenifer

AU - Lamprou, Dimitrios A.

AU - McIntosh, Lisa

AU - Oswald, Iain D. H.

AU - Urquhart, Andrew J.

PY - 2013

Y1 - 2013

N2 - Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

AB - Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

U2 - 10.1039/c3cc41583j

DO - 10.1039/c3cc41583j

M3 - Journal article

C2 - 23624643

SN - 1359-7345

VL - 49

SP - 5082

EP - 5084

JO - Chemical Communications

JF - Chemical Communications

IS - 44

ER -

Beta-adrenoceptor antagonists affect amyloid nanostructure: amyloid hydrogels as drug delivery vehicles

Abstract

Access to Document

OpenUrl availability

Fingerprint

Cite this